Blinatumomab Intravenous and Lenvatinib
Determining the interaction of Blinatumomab Intravenous and Lenvatinib and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: blinatumomab
Brand name: Blincyto
Synonyms: Blinatumomab
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Blinatumomab Intravenous-Lenvatinib Mesylate
- Blinatumomab Intravenous-Lenvima
- Blinatumomab Intravenous-Lenvima (14 MG Daily Dose)
- Blinatumomab Intravenous-Lenvima (18 MG Daily Dose)
- Blinatumomab Intravenous-Lenvima (20 MG Daily Dose)
- Blinatumomab Intravenous-Lenvima (24 MG Daily Dose)
- Lenvatinib-Blincyto
- Lenvatinib-Blisovi 24 Fe
- Lenvatinib-Blisovi 24 FE birth control
- Lenvatinib-Blisovi Fe 1.5/30
- Lenvatinib-Blisovi Fe 1/20
- Lenvatinib-Blocadren